Postoperative Pain Management Market

The global postoperative pain management market in 2020 is estimated for more than US$ 32.8 Bn and expected to reach a value of US$ 50.2 Bn by 2028 with a significant CAGR of 5.5%

 

Reports and Insights (R&I) has published a new report titled, Postoperative Pain Management Market: Opportunity Analysis and Future Assessment 2020 to 2028

Global Postoperative Pain Management Market, is segmented on the basis of pain type ( Acute Pain, Moderate Pain, Severe Pain), Product (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Antiepileptic Drugs, COX -2 Inhibitor, Opioids, Other Analgesics), Application (Cancer Pain, Arthritic Pain, Neuropathic Pain, Musculoskeletal Pain, Migraine), Target Area (Back, Legs, Hands & Arms and Others), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to gain traction over the forecast period between 2020 and 2028.

The global postoperative pain management market in 2020 is estimated for more than US$ 32.8 Bn and expected to reach a value of US$ 50.2 Bn by 2028 with a significant CAGR of 5.5%

As per the report, analgesics are the one and the most important part of post-operative pain management that includes various drug classes and drug forms. Analgesics in post-operative pain can be administered through various routes as required according to the patient need and ability to respond. Analgesics are available in the form of oral tablets, oral suspensions, patches, parenteral forms and others.

There are numerous types of post-operative pains for which different types of medications are prescribed. However, there is very severe pain that is mostly related to cancer, cancer has a humongous impact on the society and it is on the high as the time flows and the pain related to this incomparable. In the U.S., around, 17.5 Lakh of the population in 2018, was diagnosed with a certain type of cancer among them around 6 Lakh people died due to severe cancer symptoms. The number is burdening the American healthcare system as around 440 people per 100,000 men and women per year are being diagnosed with cancer as per the National Cancer Institute. By overviewing the epidemiology of the disease it can be expected that there will be immense growth in the post-operative pain management market in the near future.

Furthermore, Reports and Insights (R&I) acute pain is the most common type of pain having the most common symptoms, which demands mild analgesics or sedatives. In the actual perspective, it is a natural mode for informing the body regarding the pain caused by an injury, surgery, and disease or childbirth. It is an unpleasant sensory awakening in the body or in a particular part that is being damaged or affected.

As per various reports on the post-operative pain management it has been concluded that most of the pain is recorded to be after the surgery for which regular pain killer or analgesics are to be administered. From 234 million surgery in 2004 to 313 Mn surgeries in 2012 the numbers are being constantly increasing as per the world health organization. Despite such number, there is the major part of the population, which is not able to get the proper surgical and anaesthetic facilities and among a large number of people dies with pain being the prime reason. The Lancet Commission on Global Surgery (LCoGS) has now estimated and highlighted that around five billion of the world's population is not able to get safe and affordable surgical and anaesthesia care when required, among them around 30% to 35%of the is in a severe need of surgical and anaesthesia services.

R&I Study identifies some of the key participating players in Postoperative Pain Management market globally are Teva Pharmaceutical Industries Ltd., Novartis AG, Allergan plc, Mylan N.V., Pfizer Inc., Purdue Pharma L.P, Janssen Pharmaceuticals, Inc., Endo International plc, Pacira Pharmaceuticals Inc., Egalet Corporation., and GlaxoSmithKline Plc. etc.

About Reports and Insights:

Reports and Insights (R&I) is committed to provide deep insights that serve as creative tool for the client that enables it to perform confidently in the market. At R&I we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us:

Reports and Insights (R&I)

Tel: +1-(281)-619-8646

For Sales Queries: [email protected]

For New Topics and Other Info: [email protected]




US
US
1820 Avenue M, Brooklyn, NY 11230, United States
APAC
APAC
315,Shopping Center,Kota-324007,Rajasthan
APAC
APAC
Suite -104, D-20, Sector-63, Noida. Uttar Pradesh - 201014, India

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK